The effect of Mosapride citrate (cas 112885-42-4) on constipation in patients with diabetes
-
Add time:07/28/2019 Source:sciencedirect.com
ObjectiveConstipation is one of the most common gastrointestinal complications suspected to degrade the quality of life in diabetic patients. Mosapride citrate (cas 112885-42-4) is a novel selective 5-HT4 receptor agonist, which enhances gastric emptying and motility in the upper gastrointestinal tract facilitating acetylcholine release from the enteric cholinergic neurons. Since the receptors of 5-HT4 have been recently found in the lower intestine including the rectum in humans, we tested if mosapride improves constipation in diabetic patients.
We also recommend Trading Suppliers and Manufacturers of Mosapride citrate (cas 112885-42-4). Pls Click Website Link as below: cas 112885-42-4 suppliers
Prev:Comparison of the effects of esomeprazole plus Mosapride citrate (cas 112885-42-4) and botulinum toxin A on vocal process granuloma
Next:Dose-dependent effects of Mosapride citrate (cas 112885-42-4) on duodenal and cecal motility in donkeys (Equus asinus)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effect of Mosapride citrate (cas 112885-42-4) Hydrate on the Colon Cleansing Action of Polyethylene Glycol Electrolyte Lavage Solution (PEG-ELS) in Guinea Pigs08/04/2019
- Liquid chromatography–tandem mass spectrometric method for determination of Mosapride citrate (cas 112885-42-4) in equine tissues08/03/2019
- Effects of Mosapride citrate (cas 112885-42-4), a 5-HT4–Receptor Agonist, on Gastric Distension–Induced Visceromotor Response in Conscious Rats08/02/2019
- Dual Role of Mosapride citrate (cas 112885-42-4) Hydrate on the Gastric Emptying Evaluated by the Breath Test in Conscious Rats08/01/2019
- Development of a novel combination tablet containing trimebutine maleate and Mosapride citrate (cas 112885-42-4) for the treatment of functional dyspepsia07/31/2019
- Spectrophotometric determination of carbamazepine and Mosapride citrate (cas 112885-42-4) in pure and pharmaceutical preparations07/30/2019
- Dose-dependent effects of Mosapride citrate (cas 112885-42-4) on duodenal and cecal motility in donkeys (Equus asinus)07/29/2019
- Comparison of the effects of esomeprazole plus Mosapride citrate (cas 112885-42-4) and botulinum toxin A on vocal process granuloma07/27/2019
- Molecularly imprinted polymers based biomimetic sensors for Mosapride citrate (cas 112885-42-4) detection in biological fluids07/26/2019
-
Health and Chemical more >
-
Related Products